Eurofins Newsletters

Pharma Services

The Eurofins Group publishes a Pharma Services newsletter, presenting new services and analytical techniques, research projects, major events and other related topics. The newsletter is published 3 times per year.

BioPharma Newsletter 43 - March 2026

ARTICLES:

• Advancing AAV therapies to regulatory approval - Eurofins BPT supports methods for EU release
• Viral safety 2.0 - the power of next-generation sequencing
• Eurofins PSS and BPT deliver integrated EM/UM support across all phases
• How will ISO 10993-1:2025 affect the future of preclinical medical device compliance?
• Eurofins generates unique integrated capabilities offer to support clients’ biologics advancements
• Strategy Beyond the Bench: Eurofins launches new U.S. consulting chapter in MedTech strategy & policy

Download the PDF version of pharma newsletter N°43